Deputy Chief Physician at Affiliated Women’s Hospital of Jiangnan University,China
Dr. Renqiang Yu is a dedicated medical professional and researcher specializing in microbiology, immunology, and pediatrics. As Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University, he combines clinical expertise with groundbreaking research in gut microbiota, pediatric health, and oxidative stress-related conditions. His contributions have been recognized internationally through high-impact publications, successful research projects, and academic involvement as a guest associate editor for Frontiers in Microbiology.
Publication Profile
scopus
Summary of Suitability for the Award
Dr. Renqiang Yu demonstrates exceptional proficiency in clinical medicine and research. As a Deputy Chief Physician, his groundbreaking work in neonatal health, oxidative stress, and microbiota modulation exemplifies his leadership in advancing healthcare. His scholarly contributions, as evidenced by numerous high-impact publications, reflect innovative solutions to pressing medical challenges. His management of nationally funded research projects and academic collaborations highlight his capacity to bridge clinical practice with translational science, making him an outstanding candidate for recognition.
Early Academic Pursuits š
Renqiang Yu’s academic journey began with his pursuit of a Doctor of Medicine degree from Nanjing Medical University, one of the premier medical institutions in China. Born on November 3, 1986, in China, Dr. Yu exhibited a passion for medical sciences early in life. His rigorous education at Nanjing Medical University laid the foundation for his expertise in medical research and clinical practices. This phase was characterized by a blend of theoretical learning and practical exposure, fostering a solid base for his future endeavors.
Professional Experience
- Deputy Chief Physician
Affiliated Women’s Hospital of Jiangnan University
Dr. Yu oversees pediatric and neonatal care, integrating clinical research into treatment protocols. His work focuses on advancing therapeutic approaches to gut microbiota modulation and oxidative stress management.
- Guest Associate Editor
Frontiers in Microbiology
Dr. Yu contributes to the peer-review and editorial process, ensuring the dissemination of high-quality research in microbiology.
Contributions and Research Focus š¬
Dr. Yu has been instrumental in advancing medical research, particularly in the domains of neonatal health and microbiology. His recent projects include:
- National Natural Science Foundation of China (2022-2024): Focused on the role of propionate in promoting pulmonary angiogenesis in bronchopulmonary dysplasia via the Nrf2/ARE pathway. This project, funded with CNY 300,000, aims to address hyperoxia-induced neonatal conditions.
- Jiangsu Provincial Department of Science and Technology (2023-2025): Investigating the therapeutic potential of Limosilactobacillus reuteri FN041 for preventing atopic dermatitis in infants. This groundbreaking work is also supported by a grant of CNY 300,000.
Dr. Yu’s prolific research is further exemplified by his 25 publications in the past five years, covering diverse topics such as:
- The effects of nanoplastics on gut health.
- Mechanisms of cell death in bronchopulmonary dysplasia.
- The vertical transmission of probiotics from mothers to infants via breastfeeding.
- The role of antioxidants in human milk for neonatal health.
These studies, published in high-impact journals like Environmental Science-Nano, Apoptosis, and Mol Nutr Food Res, showcase his interdisciplinary approach and innovative methodologies.
Accolades and Recognition š
Dr. Renqiang Yu’s contributions have earned him widespread recognition in the medical community. His research publications have not only garnered citations but also influenced clinical practices and public health policies. Serving as a guest editor for a prestigious journal is a testament to his expertise and leadership in microbiology and neonatal research.
Moreover, his successful acquisition of research grants underscores his ability to lead projects that address critical medical challenges. These accolades highlight his dedication to advancing medical science and improving patient outcomes.
Publications (Top Notes)
- Title: Dysregulation of gut health in zebrafish by differentially charged nanoplastic exposure: an integrated analysis of histopathology, immunology, and microbial informatics.
Authors: Zhimin Xu, Yuxue Zhang, Zhihao Xu, et al., Renqiang Yu.
Journal: Environmental Science-Nano
Impact Factor: 9.473
Year: 2023
- Title: Molecular mechanisms of cell death in bronchopulmonary dysplasia.
Authors: Deng X, Bao Z, Yang X, Mei Y, Zhou Q, Chen A, Renqiang Yu.
Journal: Apoptosis
Impact Factor: 6.208
Year: 2023
- Title: Breast Milk-Derived Limosilactobacillus reuteri Prevents Atopic Dermatitis in Mice via Activating Retinol Absorption and Metabolism in Peyer’s Patches.
Authors: Qi C, Tu H, Zhao Y, Zhou J, Chen J, Hu H, Renqiang Yu.
Journal: Molecular Nutrition & Food Research
Impact Factor: 6.208
Year: 2023